Association between the polymorphism and delayed memory in first-episode schizophrenic patients.

The hematopoietically-expressed homeobox gene () played a critical role in regulating the immune system that the abnormality of which was involved in the psychopathology and cognitive deficits of psychiatric disorders. The aim of this study was to investigate the effect of rs1111875 polymorphism on the susceptibility and cognitive deficits of first-episode schizophrenic patients (FSP). We assessed cognitive function in 239 first-episode patients meeting DSM-IV for schizophrenia, and 368 healthy controls using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). The rs1111875 polymorphism was genotyped. Our results showed that the allelic and genotypic frequencies of rs1111875 polymorphism didn't differ between FSP and healthy controls (both  > 0.05) after adjusting for sex and age. Cognitive test scores in FSP were significantly lower than those in healthy controls on all scales (all  < 0.001) except for the visuospatial/constructional score ( > 0.05) after adjusting for covariates. There was a significant genotype ( < 0.05) rather than genotype × diagnosis ( > 0.05) effect on the delayed memory score after adjusting for covariates. The rs1111875 polymorphism was significantly associated with the delayed memory score in FSP ( < 0.05), but not in healthy controls ( > 0.05) after adjusting for covariates. Our findings supported that the rs1111875 polymorphism did not contribute to the susceptibility to FSP. However, this polymorphism might influence the delayed memory in FSP. Moreover, FSP had poorer cognitive function than healthy controls except for the visuospatial/constructional domain.